---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-161572"
form_type: "8-K"
ticker: "NMRA"
cik: "0001885522"
company_name: "Neumora Therapeutics, Inc."
filed_at: "2024-06-14T23:59:59+00:00"
generated_at: "2026-06-01T04:26:36.085390+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Neumora stockholders elect Gosebruch and Burow as Class I directors, ratify EY as auditor

## Summary
- Henry O. Gosebruch elected with 88,190,874 votes for, 2,313,739 withheld, and 12,544,469 broker non-votes.
- Kristina Burow elected with 87,022,169 votes for, 3,482,444 withheld, and 12,544,469 broker non-votes.
- Ratification of Ernst & Young as auditor for FY2024: 102,921,992 for, 123,868 against, 3,222 abstentions.
- As of record date April 15, 2024, 159,452,584 shares were outstanding and entitled to vote.

## SEC filing metadata
- accession: 0001193125-24-161572
- form_type: 8-K
- ticker: NMRA
- cik: 0001885522
- company_name: Neumora Therapeutics, Inc.
- filed_at: 2024-06-14T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1885522/000119312524161572/0001193125-24-161572-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1885522/000119312524161572/d788157d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-161572
- JSON: https://secwatch.observer/filing/0001193125-24-161572.json
- Plain text: https://secwatch.observer/filing/0001193125-24-161572.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.